212 related articles for article (PubMed ID: 21964314)
1. Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells.
Lee SH; Hao E; Levine F; Itkin-Ansari P
Islets; 2011; 3(6):358-66. PubMed ID: 21964314
[TBL] [Abstract][Full Text] [Related]
2. The Id3/E47 axis mediates cell-cycle control in human pancreatic ducts and adenocarcinoma.
Lee SH; Hao E; Kiselyuk A; Shapiro J; Shields DJ; Lowy A; Levine F; Itkin-Ansari P
Mol Cancer Res; 2011 Jun; 9(6):782-90. PubMed ID: 21498546
[TBL] [Abstract][Full Text] [Related]
3. DNA Damage Does Not Cause BrdU Labeling of Mouse or Human β-Cells.
Sharma RB; Darko C; Zheng X; Gablaski B; Alonso LC
Diabetes; 2019 May; 68(5):975-987. PubMed ID: 30833468
[TBL] [Abstract][Full Text] [Related]
4. FTY720 normalizes hyperglycemia by stimulating β-cell in vivo regeneration in db/db mice through regulation of cyclin D3 and p57(KIP2).
Zhao Z; Choi J; Zhao C; Ma ZA
J Biol Chem; 2012 Feb; 287(8):5562-73. PubMed ID: 22194608
[TBL] [Abstract][Full Text] [Related]
5. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.
Deed RW; Hara E; Atherton GT; Peters G; Norton JD
Mol Cell Biol; 1997 Dec; 17(12):6815-21. PubMed ID: 9372912
[TBL] [Abstract][Full Text] [Related]
7. Heme Oxygenase-1 (HMOX-1) and inhibitor of differentiation proteins (ID1, ID3) are key response mechanisms against iron-overload in pancreatic β-cells.
Hamad M; Mohammed AK; Hachim MY; Mukhopadhy D; Khalique A; Laham A; Dhaiban S; Bajbouj K; Taneera J
Mol Cell Endocrinol; 2021 Dec; 538():111462. PubMed ID: 34547407
[TBL] [Abstract][Full Text] [Related]
8. Targeted demethylation at the CDKN1C/p57 locus induces human β cell replication.
Ou K; Yu M; Moss NG; Wang YJ; Wang AW; Nguyen SC; Jiang C; Feleke E; Kameswaran V; Joyce EF; Naji A; Glaser B; Avrahami D; Kaestner KH
J Clin Invest; 2019 Jan; 129(1):209-214. PubMed ID: 30352048
[TBL] [Abstract][Full Text] [Related]
9. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer.
Carey JP; Asirvatham AJ; Galm O; Ghogomu TA; Chaudhary J
BMC Cancer; 2009 Jun; 9():173. PubMed ID: 19500415
[TBL] [Abstract][Full Text] [Related]
10. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle control of β-cell replication in the prenatal and postnatal human pancreas.
Köhler CU; Olewinski M; Tannapfel A; Schmidt WE; Fritsch H; Meier JJ
Am J Physiol Endocrinol Metab; 2011 Jan; 300(1):E221-30. PubMed ID: 20978233
[TBL] [Abstract][Full Text] [Related]
12. Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.
Chen P; O'Neal JF; Ebelt ND; Cantrell MA; Mitra S; Nasrazadani A; Vandenbroek TL; Heasley LE; Van Den Berg CL
PLoS One; 2010 May; 5(5):e10443. PubMed ID: 20454618
[TBL] [Abstract][Full Text] [Related]
13. ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells.
Asirvatham AJ; Carey JP; Chaudhary J
Prostate; 2007 Sep; 67(13):1411-20. PubMed ID: 17639499
[TBL] [Abstract][Full Text] [Related]
14. Histone H2AX phosphorylation induced by selective photolysis of BrdU-labeled DNA with UV light: relation to cell cycle phase.
Huang X; King MA; Halicka HD; Traganos F; Okafuji M; Darzynkiewicz Z
Cytometry A; 2004 Nov; 62(1):1-7. PubMed ID: 15455410
[TBL] [Abstract][Full Text] [Related]
15. Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells.
Chaudhary J; Johnson J; Kim G; Skinner MK
Endocrinology; 2001 May; 142(5):1727-36. PubMed ID: 11316735
[TBL] [Abstract][Full Text] [Related]
16. Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans.
Doran AC; Lehtinen AB; Meller N; Lipinski MJ; Slayton RP; Oldham SN; Skaflen MD; Yeboah J; Rich SS; Bowden DW; McNamara CA
Circ Res; 2010 Apr; 106(7):1303-11. PubMed ID: 20185798
[TBL] [Abstract][Full Text] [Related]
17. Interaction of Inhibitor of DNA binding 3 (Id3) with Gut-enriched Krüppel-like factor (GKLF) and p53 regulates proliferation of vascular smooth muscle cells.
Wassmann K; Mueller CF; Becher UM; Werner C; Jung A; Zimmer S; Steinmetz M; Nickenig G; Wassmann S
Mol Cell Biochem; 2010 Jan; 333(1-2):33-9. PubMed ID: 19618124
[TBL] [Abstract][Full Text] [Related]
18. Id3 modulates cellular localization of bHLH Ptf1-p48 protein.
Dufresne M; Clerc P; Dieng M; Edir A; Couvelard A; Delisle MB; Fourmy D; Gigoux V
Int J Cancer; 2011 Jul; 129(2):295-306. PubMed ID: 20830706
[TBL] [Abstract][Full Text] [Related]
19. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells.
Ji Y; Pos Z; Rao M; Klebanoff CA; Yu Z; Sukumar M; Reger RN; Palmer DC; Borman ZA; Muranski P; Wang E; Schrump DS; Marincola FM; Restifo NP; Gattinoni L
Nat Immunol; 2011 Nov; 12(12):1230-7. PubMed ID: 22057288
[TBL] [Abstract][Full Text] [Related]
20. Id3 is a direct transcriptional target of Pax7 in quiescent satellite cells.
Kumar D; Shadrach JL; Wagers AJ; Lassar AB
Mol Biol Cell; 2009 Jul; 20(14):3170-7. PubMed ID: 19458195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
